Literature DB >> 21360714

Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.

Matthew Bower1, Leslie Sherwood, Yan Li, Robert Martin.   

Abstract

BACKGROUND: The use of thermal tumor ablative techniques in the pancreas is limited due to the risk of pancreatitis and damage to major vascular structures. Irreversible electroporation (IRE) is a non-thermal ablation technique that could allow ablation in the pancreas while preserving vital surrounding blood vessels. The aim of this study was to assess the safety and ablation volume of IRE in porcine pancreatic tissue.
METHODS: IRE of swine pancreases was performed using an open technique and ultrasound guidance and the animals were followed for 72 hr, 7 days, and 14 days post-IRE.
RESULTS: All pigs underwent IRE, with one pig was unsuccessful after three attempts using at 3,000 V due to inability to achieve a stable current. All animals recovered well and revealed only mild adhesions, no ascites, and no pancreatic necrosis. All animals had transient increases in amylase and lipase that normalized on post-IRE day 3. Pathologic analysis revealed that ablation defects (median size 3 cm × 2.8 cm) were seen in electroporated areas with significant destruction of the pancreatic tissue with patent vascular structures.
CONCLUSIONS: This animal model demonstrates that IRE of the pancreas performed at an optimal voltage is well tolerated, with rapid resolution of pancreatic inflammation and preservation of vascular structures.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360714     DOI: 10.1002/jso.21899

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  48 in total

1.  Use of irreversible electroporation in unresectable pancreatic cancer.

Authors:  Robert C G Martin
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

2.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

3.  Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties.

Authors:  Eliel Ben-David; Muneeb Ahmed; Mohammad Faroja; Marwan Moussa; Ayelet Wandel; Jacob Sosna; Liat Appelbaum; Isaac Nissenbaum; S Nahum Goldberg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

4.  Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.

Authors:  Stefan Fritz; Christof M Sommer; Thomas Longerich; Clemens Kuhn-Neureuther; Boris Radeleff; Jens Werner; Thilo Hackert
Journal:  Langenbecks Arch Surg       Date:  2017-04-04       Impact factor: 3.445

5.  Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.

Authors:  P Marsanic; A Mellano; A Sottile; M De Simone
Journal:  Med Biol Eng Comput       Date:  2017-01-11       Impact factor: 2.602

Review 6.  Ablation therapy for hepatocellular carcinoma: past, present and future perspectives.

Authors:  David J Niemeyer; Kerri A Simo; David A Iannitti; Iain H McKillop
Journal:  Hepat Oncol       Date:  2013-12-20

7.  Electroporation: past and future of catheter ablation.

Authors:  Christopher V DeSimone; Suraj Kapa; Samuel J Asirvatham
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08

8.  An update on the role of irreversible electroporation in locally advanced pancreatic adenocarcinoma.

Authors:  Robert C G Martin
Journal:  HPB (Oxford)       Date:  2016-08-16       Impact factor: 3.647

9.  [Irreversible electroporation - a new kid on the block?].

Authors:  O Kosiek; K Strach; J Ricke; M Pech
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

Review 10.  Irreversible electroporation and the pancreas: What we know and where we are going?

Authors:  Shamar J Young
Journal:  World J Gastrointest Surg       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.